Global Hepatitis C Testing Market Analysis 2025–2029: Opportunities for Strategic Growth

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Hepatitis C Testing Market Size Likely To Evolve From 2025 Through 2034?

The hepatitis c testing market has experienced significant growth in recent years. It is forecasted to grow from $1.24 billion in 2024 to $1.32 billion in 2025, with a compound annual growth rate (CAGR) of 6.6%. The expansion observed in the past can be linked to the increased prevalence of hepatitis C, the broadening of public health initiatives, a rise in intravenous drug use, heightened awareness of the dangers associated with hepatitis C, and governmental financial support for infectious disease management.

The hepatitis c testing market size is poised for substantial growth over the next few years. It is projected to expand to $1.68 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.2%. This expected expansion is driven by a rising need for early disease identification, improved access to healthcare, an increasing focus on preventive health, backing from international health organizations, and government efforts towards hepatitis C elimination. Noteworthy trends anticipated during this forecast period involve the widespread use of multiplex diagnostic platforms, the integration of artificial intelligence (AI) in diagnostic instruments, a pivot towards home-based testing kits, greater collaboration for developing new tests, and the introduction of cost-effective testing solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24559&type=smp

What Are The Key Drivers Of Growth In The Hepatitis C Testing Market?

The increasing occurrence of hepatitis cases is anticipated to drive the expansion of the hepatitis C testing market moving forward. Hepatitis C, a viral infection, leads to liver inflammation and has the potential for severe liver damage if not addressed. The surge in hepatitis cases primarily stems from low vaccination coverage, which leaves numerous people vulnerable and aids in the virus’s dissemination. Testing for Hepatitis C enables early identification of the virus, allowing for timely treatment to prevent liver damage and severe health issues. Furthermore, it pinpoints infected persons, aiding in containment of the spread and improving management of the disease. For example, data from April 2024 by the World Health Organization (WHO), a Switzerland-based intergovernmental body focused on global public health, indicates that more than 50 million individuals worldwide are affected by chronic hepatitis C virus infection, with about 1.0 million new cases reported annually. Consequently, the growing frequency of hepatitis cases is fueling the expansion of the hepatitis C testing market.

What Are The Major Segment Categories Driving The Hepatitis C Testing Market Growth?

The hepatitis c testing market covered in this report is segmented –

1) By Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

2) By Product: Test Kits, Instruments, Reagents, Consumables

3) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

4) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

5) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

Subsegments:

1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

Which Ongoing Trends Are Expected To Shape The Hepatitis C Testing Market Outlook?

Major companies within the hepatitis C testing market are concentrating on developing advanced solutions, such as dual antigen-antibody diagnostic tests, to enable more effective screening and monitoring of the infection. An antigen-antibody diagnostic test identifies both viral proteins (antigens) and immune response proteins (antibodies) to pinpoint both active and past infections. This combined approach provides a comprehensive evaluation of the infection status. For instance, in July 2023, Roche Diagnostics India Pvt. Ltd., an India-based provider of diagnostic tests and systems, introduced Elecsys HCV Duo. This fully automated immunoassay is capable of simultaneously and independently detecting both HCV antigens and antibodies from a single plasma or serum sample. This innovation facilitates early diagnosis, supports patient management, and aligns with India’s national strategy to eliminate hepatitis C through timely and comprehensive screening.

Which Industry Leaders Are Driving Innovation Across The Hepatitis C Testing Market?

Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, Abcam Plc, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited, BIOGENIX INC. PVT. LTD.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

What Are The Key Regional Factors Influencing The Hepatitis C Testing Market Growth?

North America was the largest region in the hepatitis C testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Hepatitis C Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24559&type=smp

Browse Through More Reports Similar to the Global Hepatitis C Testing Market 2025, By The Business Research Company

Hepatitis C Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Hepatitis Diagnostic Tests Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

Covid 19 Rapid Test Kits Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795